GlaxoSmithKline, Pfizer to combine consumer health businesses in JV
GSK said on Wednesday the deal laid the foundation for the creation of two new UK-based global companies focused on Pharmaceuticals/Vaccines and Consumer Healthcare
 "GlaxoSmithKline, gsk")
GSK’s assets include the popular malt-based drinks Horlicks and Boost
GlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), majority owned by the British company.
GSK said on Wednesday the deal laid the foundation for the creation of two new UK-based global companies focused on Pharmaceuticals/Vaccines and Consumer Healthcare.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 19 2018 | 12:49 PM IST